Market Place
Sourcing Support
All News #Library
Biotech
RedHill`s RHB-204 Shows Comparable Efficacy To RHB-104
30 Apr 2026 //
PR NEWSWIRE
RedHill Advances RHB-102 for GLP-1 GI Side Effects
05 Jan 2026 //
PR NEWSWIRE
Redhill Bio Opaganib Shows Promise In Venetoclax-Resistant Cells
15 Dec 2025 //
PR NEWSWIRE
RedHill Begins Ph2 Opaganib/Darolutamide Study in Prostate Cancer
01 Jul 2025 //
PR NEWSWIRE
RedHill Announces New U.S. Patent For Opaganib, Valid Until 2041
30 Sep 2024 //
PR NEWSWIRE
Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 Mortality
03 Sep 2024 //
PR NEWSWIRE
RedHill Enrolls First COVID-19 Govt-Supported Study Patient
24 Apr 2024 //
PR NEWSWIRE
An antiviral once tested for COVID works in mice with Ebola
03 Oct 2023 //
FIERCE BIOTECH
RedHill`s RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial
31 Jul 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.